Omega Diagnostics (RVKA) AI Stock Analysis

Omega Diagnostics

(Frankfurt:RVKA)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Low leverageVery low leverage limits interest and refinancing pressure, preserving financial flexibility during operational weakness. The conservative balance sheet can support continued investment in diagnostic products and give management more room to address losses without excessive dependence on debt funding.

Negative Factors

Revenue contractionThe recent reversal from strong growth to two years of contraction signals that demand or execution has not yet become dependable. Lower revenue reduces the scale available to absorb operating costs, makes recovery harder to forecast, and can weaken the company’s ability to fund product development internally.

Omega Diagnostics (RVKA) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 3.69M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -0.6
Beta (1Y): 0.59
Revenue Growth: -18.45%
EPS Growth: -455.70%
Country: Germany
Employees: 85
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Instruments & Supplies

Omega Diagnostics Business Overview & Revenue Model

Company Description

Established in 1987 and headquartered in London, UK, Cambridge Nutritional Sciences plc (formerly Omega Diagnostics Group PLC until its name change in September 2023) is a specialist in the development, manufacturing, and supply of medical diagnostic...

Omega Diagnostics Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:RVKA against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GB:TSTL	80Outperform	GBP 194.70M	24.28	23.05%	3.51%	10.02%	19.83%
GB:AMS	67Neutral	GBP 611.34M	166.18	1.44%	1.66%	6.05%	-60.00%
GB:EKF	64Neutral	GBP 102.71M	41.38	3.58%	―	2.26%	-57.04%
GB:IXI	64Neutral	GBP 25.73M	-5.99	-16.18%	―	13.04%	15.88%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
GB:ABDX	46Neutral	GBP 22.75M	-16.36	-34.31%	―	30.42%	43.16%

* Healthcare Sector Average

Performance Comparison

DE:RVKA and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:RVKA	Omega Diagnostics	0.01	-0.01	-38.10%
GB:AMS	Advanced Medical Solutions	282.50	67.49	31.39%
GB:EKF	EKF Diagnostics Holdings	24.00	-2.20	-8.40%
GB:IXI	IXICO plc	11.75	0.25	2.17%
GB:TSTL	Tristel plc	405.00	58.67	16.94%
GB:ABDX	Abingdon Health PLC	9.00	2.75	44.00%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Omega Diagnostics AI Stock Analysis